arrow
Return

Red flags for multiple system atrophy

delete2008-04-28
delete185
delete
OA
AI
M
Martin Köllensperger
F
Felix Geser
K
Klaus Seppi
M
Michaela Stampfer‐Kountchev
C
Christoph Scherfler
S
Sylvia Boesch
J
Joerg Mueller
N
Niall Quinn
M
Maria Teresa Pellecchia
P
Paolo Barone
N
Nicole Schimke
R
Richard Dodel
W
Wolfgang H. Oertel
E
E. Dupont
K
Karen Østergaard
C
Christine Daniels
G
Günther Deuschl
T
Tanya Gurevich
N
Nir Giladi
M
Miguel Coelho
C
Cristina Sampaio
C
Christer Nilsson
H
Håkan Widner
F
Francesca Del Sorbo
A
Alberto Albanese
A
Adriana Cardozo
E
Eduardo Tolosa
M
Michael Abele
T
Thomas Klockgether
C
Christoph Kamm
T
Thomas Gasser
R
Ruth Djaldetti
C
Carlo Colosimo
G
G. Meco
A
Anette Schrag
P
Poewe, Wemer
G
Gregor K. Wenning *
DOI:10.1002/mds.21992delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
The clinical diagnosis Of Multiple system atrophy (MSA) is fraught with difficulty and there are no pathognomonic features to discriminate the parkinsonian variant (MSA-P) from Parkinson's disease (PD). Besides the poor response to levodopa, and the additional presence of pyramidal or cerebellar signs (ataxia) or autonomic failure as major diagnostic criteria, certain other clinical features known as red flags or warning signs may raise the clinical suspicion of MSA. To study the diagnostic role of these features in MSA-P versus PD patients, a standardized red flag check list (RFCL) developed by the European MSA Study Group (EMSA-SG) was administered to 57 patients with probable MSA-P and 116 patients with probable PD diagnosed according to established criteria. Those red flags with a specifity over 95% were selected for further analysis. Factor analysis was applied to reduce the number of red flags. The resulting set was then applied to 17 patients with possible MSA-P who on follow-up fulfilled criteria of probable MSA-P. Red flags were grouped into related categories. With two or more of six red flag categories present specificity was 98.3% and sensitivity was 84.2% in our cohort. When applying these criteria to patients with possible MSA-P, 76.5% of them would have been correctly diagnosed as probable MSA-P 15.9 (+/- 7.0) months earlier than with the Consensus criteria alone. We propose a combination of two out of six red flag categories as additional diagnostic criteria for probable MSA-P. (C) 2008 Movement Disorder Society.
Keywords:
multiple system atrophy
diagnosis
red flags
warning signs

Journal

Movement Disorders cover
Movement Disorders
IF:
7.6
Papers:
1.1W
Citations:
3.3W

Organization

F
Fondazione IRCCS Istituto Neurologico Carlo Besta
Scholars:
4.0K
Papers: 2.4K
Citations: 3.8K
U
universidade de lisboa
Scholars:
3.4W
Papers: 3.1W
Citations: 29
T
tel aviv sourasky medical center
Scholars:
2.9K
Papers: 2.0K
Citations: 2
U
university of kiel
Scholars:
2.3W
Papers: 1.8W
Citations: 15
U
university of bonn
Scholars:
3.3W
Papers: 2.6W
Citations: 29
P
Philipps University Marburg
Scholars:
1.3W
Papers: 1.0W
Citations: 10
A
Aarhus University
Scholars:
4.3W
Papers: 4.2W
Citations: 4.8W
L
lund university
Scholars:
4.1W
Papers: 3.9W
Citations: 54
U
University College London
Scholars:
7.9W
Papers: 6.2W
Citations: 15.7W
S
Sackler Faculty of Medicine
Scholars:
8.8K
Papers: 6.6K
Citations: 4
U
university of barcelona
Scholars:
6.1W
Papers: 4.5W
Citations: 74
U
university of london
Scholars:
21.5W
Papers: 19.7W
Citations: 305
U
University of Naples Federico II
Scholars:
4.7W
Papers: 3.6W
Citations: 51
T
Tel Aviv University
Scholars:
3.7W
Papers: 3.0W
Citations: 3.6W
M
Medical University of Innsbruck
Scholars:
1.4W
Papers: 9.9K
Citations: 10
researcher View more organizations
Cited Papers

Cited Papers

Marked asymmetry of putaminal pathology in an MSA-P patient with Pisa syndrome
err2003-11-25
err16
PREAI
errHozumi, I; Piao, YS; Inuzuka, T; Matsuyama, Z; Yamada, Y; Hara, A; Hirose, T; Tsuchiya, K; Takahashi, H
errShare
errSave
Regulation and Functional Significance of 5-Hydroxymethylcytosine in Cancer
err2017-11-23
err0
errOAAI
errVittal Rangan Arvinden; Arunagiri Kuha Deva Magendhra Rao; Thangarajan Rajkumar; Samson Mani
errShare
errSave
errShare
errSave
Kinetics of BMP-2 Release from Collagen Carrier: Evaluation by Enzyme Immunoassay in the Presence of Plasma Proteins
err2014-11-19
err0
PREAI
errE. O. Osidak; M. S. Osidak; D. E. Sivogrivov; T. S. Portnaya; T. M. Grunina; Z. M. Galushkina; V. G. Lunin; A. S. Karyagina; S. P. Domogatskii
errShare
errSave
Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?
err2002-11-26
err104
PREAI
errOsaki, Y; Ben-Shlomo, Y; Wenning, GK; Daniel, SE; Hughes, A; Lees, AJ; Mathias, CJ; Quinn, N
errShare
errSave
The natural history of Parkinson's disease
err1996-12-01
err63
PREAI
errPoewe, WH; Wenning, GK
errShare
errSave
Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: A clinicopathological study
err1996-06-01
err336
errOAAI
errLitvan, I; Mangone, CA; McKee, A; Verny, M; Parsa, A; Jellinger, K; DOlhaberriague, L; Chaudhuri, KR; Pearce, RKB
errShare
errSave
researcher View more